Knowledge Translation

The Adoption of Personalized Medicine

Although the benefits of personalized medicine have been proven in several examples, the adoption of P4™ Medicine, medicine that is Preventative, Predictive, Personalized and Participative, poses many challenges. To pave the way for its adoption, Cepmed is developing education and promotion programs aimed at empowering health-care workers, patients, policy-makers and regulatory bodies with the knowledge and evidence they need to accelerate adoption.

Cepmed also serves as an umbrella organization for stakeholders conducting personalized medicine research, education and promotion in various fields. It provides networking opportunities and a forum for debating the various issues confronting personalized medicine adoption.

Patients and Personalized Medicine

Although the patient information that is used in personalized medicine is complex, optimizing treatments according to this information is systematic compared to more traditional approaches. This results in treatment decisions that are less intuitive and more evidence based.

It is critical that patients understand the value of their personal biological information and the ways that they can benefit from this information through disease prevention and optimization of care. Cepmed’s public education campaign will be carried out independently as well as in collaboration with patient groups, medical organizations, the media, and other stakeholders to maximize impact.

Physicians and Personalized Medicine

Physician surveys in Canada and in the US indicate that although physicians recognize the value of stratified medicine they do not have the information and resources needed to incorporate a personalized approach in their practice. Currently stakeholders in personalized medicine do not have a clear view of the state of the adoption of personalized medicine in Canada. To fill this void, Cepmed has funded a Canada-wide physician survey and established expert panels to work toward developing Canadian medical guidelines and reimbursment best practices.